| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Lung Diseases, National Heart, Lung, and Blood Institute, Bethesda, MD.
Correspondence to: Suzanne Hurd, PhD, Division of Lung Diseases, National Heart, Lung, and Blood Institute, 6701 Rockledge Dr, Suite 10122, Bethesda, MD, 20892
Information on the prevalence of COPD was obtained from vital statistics, health interview surveys, hospital charge records, national publications, and the World Health Organization (WHO). These data indicate that COPD is a common disease with implications for global health. In the United States, morbidity caused by COPD is 4%, making COPD the fourth leading cause of death, exceeded only by heart attacks, cancer, and stroke. Internationally, there is substantial variation in death rates possibly reflecting smoking behavior, type and processing of tobacco, pollution, climate, respiratory management, and genetic factors. The Global Obstructive Lung Disease Initiative, initiated by the National Heart, Lung, and Blood Institute and the WHO, aims to raise awareness of the increasing burden of COPD, decrease morbidity and mortality, promote further study of the condition, and implement programs to prevent COPD.
Key Words: COPD • education programs • morbidity • public health
This article has been cited by other articles:
|
|
 |
|
  S. Christensen, R. W. Thomsen, M. L. Torring, A. Riis, M. Norgaard, and H. T. Sorensen Impact of COPD on Outcome Among Patients With Complicated Peptic Ulcer Chest, June 1, 2008; 133(6): 1360 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Leidy Evolving Concepts in the Measurement of Treatment Effects Proceedings of the ATS, May 1, 2006; 3(3): 212 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Lopez, K. Shibuya, C. Rao, C. D. Mathers, A. L. Hansell, L. S. Held, V. Schmid, and S. Buist Chronic obstructive pulmonary disease: current burden and future projections Eur. Respir. J., February 1, 2006; 27(2): 397 - 412. [Full Text] [PDF]
|
|
|
|
|
|
R. Buhl and S. G. Farmer Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kim, X. Liu, T. Kobayashi, H. Conner, T. Kohyama, F.-Q. Wen, Q. Fang, S. Abe, P. Bitterman, and S. I. Rennard Reversible Cigarette Smoke Extract-Induced DNA Damage in Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa Inhaled steroids and mortality in COPD: bias from unaccounted immortal time Eur. Respir. J., March 1, 2004; 23(3): 391 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.L. Hansell, J.A. Walk, and J.B. Soriano What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis Eur. Respir. J., November 1, 2003; 22(5): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Malhotra, A. P. Peiffer, D. T. Ryujin, T. Elsner, R. E. Kanner, M. F. Leppert, and S. J. Hasstedt Further Evidence for the Role of Genes on Chromosome 2 and Chromosome 5 in the Inheritance of Pulmonary Function Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 556 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD Chest, August 1, 2003; 124(2): 459 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa Effectiveness of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Immortal Time Bias in Observational Studies Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 49 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Epstein Inhaled Corticosteroids and Chronic Obstructive Pulmonary Disease: Are We Barking Up the Wrong Tracheobronchial Tree? Ann Intern Med, June 17, 2003; 138(12): 1001 - 1002. [Full Text] [PDF]
|
|
|
|
|
|
P. Buch, J. Friberg, H. Scharling, P. Lange, and E. Prescott Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study Eur. Respir. J., June 1, 2003; 21(6): 1012 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shin, K. H. In, J. J. Shim, S. H. Yoo, K. H. Kang, M. Hong, and K. Choi Prevalence and Correlates of Airway Obstruction in a Community-Based Sample of Adults Chest, June 1, 2003; 123(6): 1924 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.D. Sullivan, A.S. Buist, and K. Weiss Health outcomes assessment and economic evaluation in COPD: challenges and opportunities Eur. Respir. J., June 1, 2003; 21(41_suppl): 1S - 3s. [Full Text] [PDF]
|
|
|
|
|
|
J. Bourbeau Inhaled corticosteroids and survival in chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 202 - 203. [Full Text] [PDF]
|
|
|
|
|
|
D.D. Sin and S.F.P. Man Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur. Respir. J., February 1, 2003; 21(2): 260 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rennard, M. Decramer, P.M.A. Calverley, N.B. Pride, J.B. Soriano, P.A. Vermeire, and J. Vestbo Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Eur. Respir. J., October 1, 2002; 20(4): 799 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Aalbers, J. Ayres, V. Backer, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, and G.W. Sybrecht Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Eur. Respir. J., May 1, 2002; 19(5): 936 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Almagro, E. Calbo, A. Ochoa de Echaguen, B. Barreiro, S. Quintana, J. L. Heredia, and J. Garau Mortality After Hospitalization for COPD* Chest, May 1, 2002; 121(5): 1441 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. SIN and J. V. TU Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 580 - 584. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
